Stay informed with the latest updates on highly pathogenic avian influenza (HPAI) A(H5N1), or bird flu.
Pink eye, also known as conjunctivitis, is highly contagious. Herbert Ingraham, MD, an ophthalmologist at Geisinger, shares more about pink eye.
CPT Editorial Panel accepts new Appendix S for classifying artificial intelligence/augmented intelligence (AI) applications for medical services and procedures.
Find information about CPT code 90695 for reporting avian (bird) flu immunizations.
Access resources and guidance for CME providers and the AMA PRA credit system. Also learn more about the PRA meaning and key points.
Explore the AMA's specific requirements for faculty to obtain CME credit for teaching medical students and residents.
Find information about the responsibilities and terms of service for the student representative on the Liaison Committee on Medical Education and how to apply.
AMA member Amish J. Dave, MD, MPH, says rheumatologists must be comfortable with diagnostic uncertainty and ready to help patients navigate treatments.
Becoming chief resident can dramatically change your postgraduate experience. Co-chief resident Nicolas K. Fletcher, MD, breaks down what to expect.
Many final-year resident and fellow physicians find employment in hospitals and health systems. Get up to speed with these must-have contracting tips.
Registration open: Live July 17 webinar with CMS staff on new ACO PC Flex Model and more in the latest Medicare Payment Reform Advocacy Update.
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about AMA priorities and policy goals.
The poster session and networking reception will take place during the 2024 Interim Meeting. Learn more.
The 2024 International Conference on Physician Health will be held Oct. 17–Oct. 19, 2024. Learn more.
The July 18, 2024 Speakers' Update provides further clarification on group definitions for endorsements, and a new candidate code of conduct.
Read the House of Delegates (HOD) speakers' updates for the 2024 HOD Interim Meeting.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
Leadership of the seven MSS Regions is responsible for policy development and facilitate engagement and collaboration between local campus sections.
Read the June YPS highlights from YPS Chair Jordan Warchol, MD, MPH.
In the news: Physical activity and longevity, TikTok health advice, long COVID data, childhood immunizations and more.
Find out how to apply for a seat on the CPT Editorial Panel or the CPT Advisory Committee.
Prior authorization requirements can lead to negative clinical outcomes. Get the latest resources and information and learn more about how the AMA is leading reforms around prior authorization.
The AMA is leading the fight against the COVID-19 pandemic. See daily video updates on how the AMA is fighting COVID-19 by discussing trending topics related to the pandemic such as the B.1.1.7 variant.
Health insurer requirements for advanced approvals associated with treatment delays, care disruption, and patient harm.
Download guidance and issue brief PDFs—the AMA provides policy recommendations to help guide policymakers to reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
There is a growing overlap between state and federal policymaking. Learn how AMA advocacy teams are prepared to tackle issues in either venue.
President signs omnibus spending package providing new round of COVID-19 relief and more in the latest National Advocacy Update.
It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.
AMA, Mannatt report emphasizes the increasing importance of removing barriers to evidence-based care.
Learn about the policy steps that must be taken to improve access to lifesaving substance-use disorder treatment.
